Summary Our studies of the metastatic behaviour of FSA1231 and FSA1233 show that the role of selection processes of metastatic variants at the secondary sites is minimal in the spontaneous metastasis of these systems. In contrast, tumour-cell release efficiency (number of blood-borne clonogenic tumour-cells) correlates well with the difference in spontaneous lung metastasis efficiencies of the cell clones FSA1231 and FSA1233. Also, the different tumour-cell release efficiencies could explain the discrepancy between artificial and spontaneous metastasis of these cell clones.
Metastasis involves multiple complex steps, from tumour-cell release into the systemic circulation to deposition and new growth at the secondary sites. Numerous studies of over 20 years on patients' blood failed to establish a positive correlation between the presence of tumour cells in the blood and prognosis (Goldblatt & Nadel, 1965; Salsbury, 1975) . This negative conclusion on the role of blood-borne tumour cells along with a view of organ specific distribution of metastasis, which is attractive and had been a subject of controversy for many years, might have led investigators' attention to the selection processes at the secondary sites. Heterogeneity of metastatic potential among tumour cells and selection processes of metastatic variants at the secondary sites have been the major focus of metastasis studies in the past 10 years from many laboratories (Fidler, 1973; Nicolson & Winkelhake, 1975 , Fidler & Kripke, 1977 Brunson et al., 1978; Dexter et al., 1978; Neri et al., 1982; Nicolson & Custead, 1982; Raz et al., 1981; Talmadge & Fidler, 1982;  reviews; Fidler et al., 1978; Poste & Fidler, 1980 , Fidler & Hart, 1982 including our own , 1979 . One of the hypotheses advocated by many of these studies is that metastatic foci may be formed by cells from a primary tumour which are unique in their capability to metastasize, i.e., metastatic cells evolve from the primary tumour cell population as a result of the production of variants during neoplastic development (Foulds, 1969) , and then selection of suitable ones for metastasis occurs through metastatic processes.
In these studies, heterogeneity of metastatic potential among tumour cells is well established.
However, the role of selection processes in spontaneous metastasis remains to be determined.
Recent studies on our FSA cell clone system (clones isolated from a methylcholanthrene-induced mouse fibrosarcoma) showed that FSA1231 cells are more efficient in spontaneous lung metastasis than FSA1233 cells, while FSA1233 cells are more efficient in artificial lung metastasis through i.v. injection than FSA1231 cells (Suzuki et al., 1980) . Therefore, the FSA1231-1233 cell system discriminates artificial and spontaneous lung metastatic processes. More evidence supporting the idea that spontaneous and artificial metastasis are not necessarily the same has come from other laboratories also using different tumour systems (Mantovani et al., 1981; Stackpole, 1981; Sweeney et al., 1982) . We have also added further data indicating a difference between the two methods, i.e., involvement of host/primary-tumour interactions and/or tumour-cell release affecting spontaneous metastasis (effect of whole body irradiation) (Suzuki, 1983a) .
Thus, selection processes (e.g., through organ specific affinity, Nicolson & Winkelhake, 1975) at the secondary sites for metastatic variants do not explain the clonal difference of the present system, i.e., if the selection at the secondary sites is the main determinant of metastasis, a clone superior to another should be so in either artificial or spontaneous metastasis. Selection processes at the secondary sites may not be critical determinants in spontaneous metastasis of the present system. Previous studies with this system showed that lung nodules increase faster in size in FSA1231 tumourbearing mice than in those with FSA1233 tumours. Tumour-cell release (TCR) processes and host changes during primary tumour growth, which are not involved in artificial metastasis, may be more important. Such a hypothesis seems to offer a better explanation of the metastatic behaviour of the FSA1231 and FSA1233 clones.
In the present investigation, we first examined whether cells cultured from metastatic nodules in the lung (spontaneously arising after production of a primary tumour by i.m. inoculation of tumour cells in a leg) had enhanced spontaneous metastatic ability compared with the original tumour cells. Secondly, we examined the efficiency of tumour-cell release (TCR) by quantitating blood-borne clonogenic tumour-cells with a clonogenicity assay in vitro of lung-trapped tumour cells during 22h after 150Gy of thorax irradiation (lung-mediated CTCR rate assay) (Suzuki, 1983b) .
Materials and methods
Tumour cells FSA cell clones were isolated by soft agar cloning in vitro ) from a syngeneic fibrosarcoma to C3H/HeJ mice. The cell clones have been characterized regarding their malignant and related properties 1979; Suzuki et al., , 1980 Spontaneous lung metastasis efficiency (SLME) determination For determination of SLME, 106 cells were inoculated i.m. into the hind leg of each syngeneic C3H/HeJ mouse (male, 9-11 weeks old; purchased from The Jackson Laboratories, Bar Harbor, Maine). Mice were killed after 45 days, the lungs were placed in Bouin's fluid, and surface nodules were macroscopically counted . In these conditions, primary tumours develop in 100% of inoculation sites. For indirect estimate of timing and efficiency of TCR (metastatic spread), amputation was performed at specified times after the tumour cell inoculation under pentobarbital sodium anesthesia (40mgkg-1) with cauterization of major blood vessels, and the mice were killed 20 days later.
Testfor variant selection
The cells from secondary nodules, which were developed by the standard SLME determination method or i.v. injection method, were propagated in culture about 10 days prior to injection for SLME measurement.
Lung-mediated assay of blood-borne clonogenic tumor cells (CTCR rate assay) The method has been described in detail elsewhere (Suzuki, 1983b) . Mice were inoculated i.m. in a hind leg with 106 FSA1231 or FSA1233 cells suspended in 0.1 ml medium. The cell suspensions were prepared from late log phase in vitro cultures. The mice were irradiated with 150Gy locally at the thorax 32-40 days later using a 137Cs y-ray irradiator at 11.5 Gy min-under anesthesia with pentobarbital sodium (40 mg kg-1). The thorax irradiation was intended to eradicate tumour cells already metastasized to the lung as well as normal cells in the lung, and also possibly to enhance lung trapping and retention of tumour cells (Fidler & Zeidman, 1972; Brown, 1973; Van den Brenk, 1973; Withers & Milas, 1973; Peters et al., 1978 Peters et al., , 1980 Grdina et al., 1978) . The mice (3 mice per group) were killed immediately (Oh-control) or 22h after irradiation. Appropriateness of thorax irradiation setting is obvious from the fact that there were no tumour cell colonies in Oh control flasks ( Figure 1 ). Thus, colonies formed in 22h groups are those of newly released and lung-trapped tumour cells during the 22 h. The lungs were removed and rinsed with cold physiological saline, minced with scissors, incubated for 1 h at 37°C with 1 mg ml-neutral protease (Type IX, Sigma Chemical Co., St. Louis, Mo.) and 1 mg ml -1 DNase I (DN-25, Sigma Chemical Co.) in Puck's saline G and then stirred for 30 min at room temperature. The whole preparation was washed 3 times by centrifugation. The cell suspensions were placed with 5 x 104ml-of 120Gy irradiated feeder cells (FSA1231 or FSA1233 cells) in 150cm2 flasks (Corning Glass Works, Coming, New York) containing 20 ml McCoy's 5A medium supplemented with 15% foetal bovine serum (GIBCO, Grand Island, N.Y.) (Figure 1 experiments) . Later, in the experiments of Table II , the lung suspensions were plated in 10cm dishes instead of flasks (one mouse/lOml medium/dish) without addition of feeder cells. Two days later, 10ml medium was added and thereafter medium was changed every 4 days with careful handling to avoid disrupting colonies. Colonies were stained 2 weeks later with 0.5% crystal violet solution in 95% ethanol. Malignant tumour cells, filtered from blood during the 22h incubation time after the 150 Gy thorax irradiation, formed colonies. The tumour cell colonies were large and thick compared to the background normal cells (thin colony-like growth but not reproductive one), which did not disturb counting of tumour cell colonies. The tumour cell colonies were identifiable by specific DNA content (Figure 2) (Suzuki et al., , 1980 . As a routine procedure, the cells from culture were always monitored for cell number and modal peak position of the cell volume distribution. This (Suzuki & Withers, 1979) , selection processes in the lung were clearly demonstrated for artificial lung metastasis after i.v. injection. Thus, in the FSA cell clone system, selection processes for cells with higher lung colonizing potential clearly exist for "artificial" metastasis, but such selection processes cannot be demonstrated in spontaneous metastasis from leg tumours. In previous studies (Suzuki et al., 1980) , more efficient dissemination of FSA1231 compared with FSA1233 was observed by measuring SLME at different times after i.m. inoculation of these tumour cells in the leg. In the present study, we attempted to obtain additional data on timing and efficiency of metastatic spread (tumour-cell release) by amputation of tumour-bearing legs at various times after i.m. inoculation of tumour cells. However, as a result of the necessity of amputating tumourbearing legs in the early stage to avoid difficulties in resection of large tumours, very limited numbers of metastases were obtained (data are not shown). In theory, these experiments with serial amputations of tumour bearing legs should allow an indirect estimate of the efficiency or rate of tumour-cell release (TCR), but growth processes at the secondary sites other than TCR are involved and this can affect the results. To specifically determine the role of TCR, we applied a newly developed lung-mediated CTCR rate assay for measurement of blood-borne clonogenic tumour cells (Suzuki, 1983b) . Figure 1 shows colonies in 150 cm2 flasks. Normal cells in the background were very limited (the thorax was preirradiated with 150 Gy; Oh control flasks have these background normal cells only) and did not disturb quantitation of tumour cell colonies, which were considerably larger and more dense. Microscopically, there was an obvious difference between the tumour cell colonies and colony-like normal cell growth; tumour cells were randomly overlapping while normal cells were in one layer of diffuse growth. These colonies were identified as tumour cells (Figure 2 ) by specific G1 DNA content of each cell clone, i.e., 1.6 (FSA1231) and 3.1 (FSA1233) fold greater than G1 normal cells , and tumorigenicity in the syngeneic host mice (with i.m. inoculation of 2 x 106 cells) using trypsinized cell suspensions from the flasks. Comparison of colony number and SLME for FSA1231 and FSA1233 indicates a positive correlation between the number of clonogenic tumour cells in the blood and SLME (Table II) days for tumour size and 45-61 days for SLME after i.m. inoculation, ; therefore, the higher colony number of FSA1231 over FSA1233 in Figure 1 and Table II of petri dishes shown in parentheses). Thorax irradiated normal mice were injected through a tail vein with 5 x 104/mouse tumour cells suspended in 0.25 ml medium. They were killed immediately (Oh) or 22 h later and lung cell suspensions were prepared in the same manner as CTCR assay.
Corrected CTCR rate: (combined CTCR rate/mean of % recovery at 0 and 22 h) x 100. SLME: Spontaneous lung metastasis efficiency. Mean +s.e. of lung nodules/mouse for shown number of mice in parentheses (from Table I (Zeidman, 1981) and exaggerate the role of organ specific selection processes in spontaneous metastasis. Therefore, we isolated spontaneous lung nodules after only one selection step and compared their spontaneous metastasis frequency with parental tumour cells. Interpretation of our negative results is somewhat unclear; it may mean either (1) selection processes may not be important in our system, (2) variants may be very unstable and may have lost the "selected" property during growth at the secondary sites or during the test procedures, or (3) the variation may not be genetic (e.g., adaptation proposed by Weiss, 1979) . However, the relatively low frequency of lung nodule formation does not favour epigenetic changes (third possibility) such as enzyme induction. The second possibility of false negativity by instability of secondary nodule cells is unlikely in the present system, since the same procedure (a single process of lung colonization, culture and test of the secondary nodule cells derived from artificial lung metastases after tail vein injection) showed a clearly demonstrable enhancement of lung colony forming efficiency (Suzuki & Withers, 1979 (Giavazzi et al., 1980; Weiss, 1983) . Thus, the metastatic variant hypothesis, which is supported mainly by the results obtained using artificial metastasis methods, obviously needs more careful examination using various spontaneous metastases systems.
We hypothesize that one possible determinant for spontaneous metastasis could be the TCR process. For example, the superiority of FSA1231 over FSA1233 in spontaneous metastasis, unlike artificial metastasis, may originate from a difference in the efficiency of TCR or entry into the circulation. Another possible important factor may be changes in the host during primary-tumour growth which may affect metastasis; artificial metastasis using healthy mice does not involve host/primary-tumour interactions. How such host/primary-tumour interactions affect clonal differences of metastasis has not been adequately studied. The possibility of promoting metastasis during diagnostic and therapeutic procedures by inducing TCR from the primary has been suspected (Kaplan & Murphy, 1949; Sheldon & Fowler, 1973; Peters 1975; Baker et al., 1981) , though numerous studies of over 20 years on patients' blood failed to establish a positive correlation between the presence of tumour cells in the blood and prognosis (Goldblatt & Nadel, 1965; Salsbury, 1975) . Interpretation of data regarding tumour cells in patients' blood is very difficult since most studies used cytological microscopic identification of fixed cells isolated from very small amounts of blood (5-10ml) (Salsbury, 1975) relative to the total human blood volume. Furthermore, in most studies, the source of the blood samples was irrelevant to tumour sites, and clonogenicity and tumorigenicity of these cells were not evaluated.
Thus, new methods for determining blood-borne "clonogenic" tumour cells are necessary to define which is (are) the most important process(es) in spontaneous metastasis. In the present study, a newly developed lung-mediated CTCR assay (Suzuki, 1983b) was used to specifically evaluate the role of TCR. This method allowed us to determine "clonogenic" tumour cells and their tumorigenicity, which microscopic identification of tumour cells after filtration of a small amount of blood does not permit. These are major advantages, since previous studies were limited by small amounts of available blood, and somewhat uncertain techniques for identification of blood-borne tumour cells (Salsbury, 1975) . During the 22h incubation time after pre-irradiation, about 1,300 ml of blood would be filtered by the lung if 1 ml min-1 for blood flow is assumed (Liotta et al., 1974) . Thus, the method allows us to determine the release rate of "clonogenic" tumour cells from the primary tumour and the method is applicable to a system with less frequent tumour cells released in the blood. This method does not require complex operations such as insertion of cannulae into the tumour blood vessels and perfusion of tumours, and similarly avoids potential perturbations of the animal and tumour by such techniques.
While the conventional conclusion elucidated from the numerous clinical studies has been that mere existence of tumour cells in the blood circulation is not indicative of poor prognosis or inevitable metastasis development (Salsbury, 1975) , the present results indicate that number of "clonogenic" tumour-cells released from the primary into the blood or clonogenic tumour-cell release rate may explain both the difference of SLME between FSA1231 and FSA1233 and the discrepancy in artificial and spontaneous metastasis efficiency of these two cell clones.
